FindTrial
Sign In

The Diagnostic Value of Metagenomic Next-Generation Sequencing in Non-Neutropenic Pulmonary Aspergillosis

The Diagnostic Value of Metagenomic Next-Generation Sequencing in Non-Neutropenic Pulmonary Aspergillosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110013
Enrollment
Unknown
Registered
2025-09-28
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Neutropenic Pulmonary Aspergillosis

Interventions

Gold Standard:Traditional fungal culture testing
Index test:Metagenomic Next-Generation Sequencing

Sponsors

Yichang Central People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.proved diagnosis of pulmonary aspergillosis; 2.Non-neutropenic patients;

Exclusion criteria

Exclusion criteria: 1.Age < 18 years old; 2.Co-existing pulmonary infection;

Design outcomes

Primary

MeasureTime frame
Accuracy;Sensitivity;Specificity;—

Countries

China

Contacts

Public ContactLi Shuhua

Yichang Central People’s Hospital

243288422@qq.com+86 717 6486192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026